John H Zhang Selected Research

H-Phe-Ser-Leu-Leu-Arg-Tyr-NH2

10/2020	Inhibition of PAR-2 Attenuates Neuroinflammation and Improves Short-Term Neurocognitive Functions Via ERK1/2 Signaling Following Asphyxia-Induced Cardiac Arrest in Rats.
1/2020	FSLLRY-NH2 Improves Neurological Outcome After Cardiac Arrest in Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John H Zhang Research Topics

Disease

182	Brain Injuries (Brain Injury) 08/2022 - 09/2002
123	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 12/2021 - 02/2002
114	Brain Edema (Cerebral Edema) 01/2022 - 08/2004
71	Hypoxia (Hypoxemia) 01/2022 - 09/2002
64	Ischemia 01/2021 - 02/2002
60	Cerebral Hemorrhage 11/2022 - 05/2004
60	Inflammation (Inflammations) 01/2022 - 07/2005
59	Hemorrhage 05/2020 - 02/2002
57	Stroke (Strokes) 10/2021 - 05/2004
50	Infarction (Infarctions) 01/2022 - 02/2002
46	Neuroinflammatory Diseases 02/2022 - 04/2010
44	Brain Ischemia (Cerebral Ischemia) 05/2020 - 02/2002
43	Ischemic Stroke 02/2021 - 09/2003
31	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2021 - 07/2006
23	Wounds and Injuries (Trauma) 01/2020 - 07/2005
22	Intracranial Vasospasm 01/2019 - 02/2002
21	Hematoma 01/2022 - 05/2004
17	Brain Infarction 01/2022 - 07/2003
17	Edema (Dropsy) 12/2020 - 04/2005
13	Hydrocephalus (Hydrocephaly) 02/2022 - 01/2011
13	Atrophy 01/2021 - 11/2009
11	Hyperglycemia 10/2021 - 03/2007
11	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020 - 06/2011
11	Body Weight (Weight, Body) 10/2016 - 03/2007
10	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 05/2020 - 02/2010
9	Neurologic Manifestations (Neurological Manifestations) 10/2020 - 07/2003
9	Reperfusion Injury 02/2019 - 05/2004
8	Hemorrhagic Stroke 01/2018 - 03/2010
6	Neoplasms (Cancer) 08/2019 - 01/2005
5	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 04/2010
5	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2017 - 05/2008
4	Seizures (Absence Seizure) 10/2020 - 03/2008
4	Asphyxia (Suffocation) 10/2020 - 07/2018

Drug/Important Bio-Agent (IBA)

63	Oxygen (Dioxygen)IBA 01/2018 - 02/2002
48	Proteins (Proteins, Gene)FDA Link 08/2022 - 02/2002
38	salicylhydroxamic acid (SHAM)IBA 01/2019 - 09/2003
37	Neuroprotective AgentsIBA 12/2020 - 07/2006
30	Small Interfering RNA (siRNA)IBA 01/2021 - 03/2009
26	Caspase 3 (Caspase-3)IBA 01/2021 - 07/2003
22	HydrogenIBA 01/2021 - 08/2008
18	CytokinesIBA 02/2021 - 11/2003
18	OsteopontinIBA 01/2020 - 02/2010
16	Collagenases (Collagenase)FDA Link 01/2018 - 10/2004
14	Hemoglobins (Hemoglobin)IBA 09/2021 - 02/2011
13	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 07/2006
13	Evans Blue (Blue, Evans)FDA Link 07/2017 - 07/2006
12	fluoro-jade CIBA 01/2022 - 03/2016
12	Isoflurane FDA LinkGeneric 10/2020 - 07/2010
12	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 03/2007
12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2016 - 08/2004
12	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2015 - 01/2007
11	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2021 - 10/2004
11	Therapeutic UsesIBA 01/2019 - 03/2002
10	AntioxidantsIBA 01/2022 - 01/2008
10	Phosphotransferases (Kinase)IBA 01/2019 - 02/2011
9	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 05/2004
9	Pharmaceutical PreparationsIBA 11/2020 - 12/2009
9	Anesthetics (Anesthetic Agents)IBA 10/2020 - 03/2009
9	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2016 - 02/2002
9	Messenger RNA (mRNA)IBA 01/2012 - 02/2002
8	Sirtuin 1IBA 10/2021 - 02/2015
8	CateninsIBA 09/2021 - 04/2012
8	Peroxidase (Myeloperoxidase)IBA 01/2018 - 06/2008
7	Tight Junction ProteinsIBA 01/2022 - 11/2009
7	IntegrinsIBA 01/2021 - 11/2010
7	Thrombin FDA Link 01/2021 - 04/2009
7	Protein Kinases (Protein Kinase)IBA 01/2021 - 08/2004
7	Erythropoietin FDA Link 01/2015 - 02/2004
7	hydrogen rich salineIBA 04/2011 - 04/2009
6	Adenosine Triphosphate (ATP)IBA 12/2021 - 07/2002
6	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 03/2021 - 07/2003
6	InflammasomesIBA 01/2021 - 10/2013
6	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2017 - 02/2002
6	Mitogen-Activated Protein KinasesIBA 01/2016 - 03/2002
6	Free RadicalsIBA 01/2016 - 04/2005
6	MelatoninIBA 01/2011 - 01/2008
6	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2007 - 02/2004
5	Immunoglobulin G (IgG)IBA 01/2021 - 04/2008
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 11/2003
5	Adenosine Monophosphate (AMP)IBA 10/2020 - 04/2017
5	Malondialdehyde (Propanedial)IBA 01/2020 - 03/2009
5	Glycoproteins (Glycoprotein)IBA 01/2018 - 02/2010
5	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2018 - 01/2011
5	Fingolimod Hydrochloride (FTY720)FDA Link 01/2017 - 02/2010
5	Coloring Agents (Dyes)IBA 01/2016 - 02/2011
5	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 06/2015 - 09/2009
4	LigandsIBA 01/2022 - 10/2020
4	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2021 - 10/2019
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2021 - 01/2018
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
4	NF-kappa B (NF-kB)IBA 01/2021 - 02/2010
4	Peptides (Polypeptides)IBA 12/2020 - 01/2011
4	Circular RNAIBA 11/2020 - 01/2018

Therapy/Procedure

66	Therapeutics 01/2021 - 03/2002
41	Ligation 01/2022 - 09/2002
19	Hyperbaric Oxygenation 01/2018 - 09/2002
13	Neurosurgical Procedures 01/2020 - 03/2007
11	Intranasal Administration 01/2021 - 11/2013
9	Electrocoagulation (Electrocautery) 01/2019 - 01/2007
5	Sutures (Suture) 01/2016 - 07/2006